Melanoma Stocks List

Recent Signals

Date Stock Signal Type
2020-02-26 ADAP Lower Bollinger Band Walk Weakness
2020-02-26 ADAP Stochastic Buy Signal Bullish
2020-02-26 AGEN Lower Bollinger Band Walk Weakness
2020-02-26 AGEN Calm After Storm Range Contraction
2020-02-26 AGEN NR7 Range Contraction
2020-02-26 AGEN Doji - Bullish? Reversal
2020-02-26 BLCM Narrow Range Bar Range Contraction
2020-02-26 BLCM Stochastic Buy Signal Bullish
2020-02-26 BLCM NR7 Range Contraction
2020-02-26 CSTL Doji - Bullish? Reversal
2020-02-26 IOVA New Uptrend Bullish
2020-02-26 IOVA Upper Bollinger Band Walk Strength
2020-02-26 IOVA Jack-in-the-Box Bullish Bullish Swing Setup
2020-02-26 IOVA Parabolic Rise Strength
2020-02-26 IOVA Pocket Pivot Bullish Swing Setup
2020-02-26 IOVA Volume Surge Other
2020-02-26 IOVA Wide Range Bar Range Expansion
2020-02-26 IOVA New 52 Week Closing High Bullish
2020-02-26 NAVB Stochastic Reached Oversold Weakness
2020-02-26 NAVB NR7 Range Contraction
2020-02-26 NLNK Stochastic Reached Oversold Weakness
2020-02-26 ONCS New 52 Week Closing Low Bearish
2020-02-26 ONCS Lower Bollinger Band Walk Weakness
2020-02-26 ONCS New 52 Week Low Weakness
2020-02-26 PDSB New 52 Week Closing Low Bearish
2020-02-26 PDSB Narrow Range Bar Range Contraction
2020-02-26 SRTS MACD Bearish Centerline Cross Bearish
2020-02-26 SRTS Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2020-02-26 SRTS Crossed Above 50 DMA Bullish
2020-02-26 SRTS Bullish Engulfing Bullish
2020-02-26 SRTS Lower Bollinger Band Walk Weakness
2020-02-26 SSKN NR7 Range Contraction
2020-02-26 SSKN Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2020-02-26 SSKN Narrow Range Bar Range Contraction
2020-02-26 VCNX MACD Bullish Centerline Cross Bullish
2020-02-26 VCNX Pocket Pivot Bullish Swing Setup
2020-02-26 VCNX Crossed Above 20 DMA Bullish

Melanoma, also known as malignant melanoma, is a type of cancer that develops from the pigment-containing cells known as melanocytes. Melanomas typically occur in the skin, but may rarely occur in the mouth, intestines, or eye. In women, they most commonly occur on the legs, while in men they are most common on the back. Sometimes they develop from a mole with changes such as an increase in size, irregular edges, change in color, itchiness, or skin breakdown.The primary cause of melanoma is ultraviolet light (UV) exposure in those with low levels of skin pigment. The UV light may be from either the sun or from other sources, such as tanning devices. About 25% develop from moles. Those with many moles, a history of affected family members, and who have poor immune function are at greater risk. A number of rare genetic defects such as xeroderma pigmentosum also increase risk. Diagnosis is by biopsy and analysis of any skin lesion that has signs of being potentially cancerous.Using sunscreen and avoiding UV light may prevent melanoma. Treatment is typically removal by surgery. In those with slightly larger cancers, nearby lymph nodes may be tested for spread. Most people are cured if spread has not occurred. For those in whom melanoma has spread, immunotherapy, biologic therapy, radiation therapy, or chemotherapy may improve survival. With treatment the five-year survival rates in the United States is 98% among those with localized disease and 17% among those in whom spread has occurred. The likelihood that it will come back or spread depends how thick the melanoma is, how fast the cells are dividing, and whether or not the overlying skin has broken down.Melanoma is the most dangerous type of skin cancer. Globally, in 2012, it newly occurred in 232,000 people. In 2015 there were 3.1 million with active disease which resulted in 59,800 deaths. Australia and New Zealand have the highest rates of melanoma in the world. There are also high rates in Northern Europe and North America, while it is less common in Asia, Africa, and Latin America. Melanoma is more common in men than women. Melanoma has become more common since the 1960s in areas which are mostly populated with white people.

More about Melanoma